Global Viral Vector Vaccine for Humans Supply, Demand and Key Producers, 2024-2030
The global Viral Vector Vaccine for Humans market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Viral vaccines are a type of vaccine used to prevent infections caused by viruses. These vaccines increase the body's resistance to a specific virus by causing the immune system to mount an immune response to that virus. Viral vaccines usually contain inactivated, attenuated viruses, their isolated antigens, or their synthetic proteins.
This report studies the global Viral Vector Vaccine for Humans production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Vector Vaccine for Humans, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Vector Vaccine for Humans that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Vector Vaccine for Humans total production and demand, 2019-2030, (K Units)
Global Viral Vector Vaccine for Humans total production value, 2019-2030, (USD Million)
Global Viral Vector Vaccine for Humans production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Viral Vector Vaccine for Humans consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Viral Vector Vaccine for Humans domestic production, consumption, key domestic manufacturers and share
Global Viral Vector Vaccine for Humans production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Viral Vector Vaccine for Humans production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Viral Vector Vaccine for Humans production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Viral Vector Vaccine for Humans market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation and BioMerieux, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Vector Vaccine for Humans market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Viral Vector Vaccine for Humans Market, By Region:
1. How big is the global Viral Vector Vaccine for Humans market?
2. What is the demand of the global Viral Vector Vaccine for Humans market?
3. What is the year over year growth of the global Viral Vector Vaccine for Humans market?
4. What is the production and production value of the global Viral Vector Vaccine for Humans market?
5. Who are the key producers in the global Viral Vector Vaccine for Humans market?
Viral vaccines are a type of vaccine used to prevent infections caused by viruses. These vaccines increase the body's resistance to a specific virus by causing the immune system to mount an immune response to that virus. Viral vaccines usually contain inactivated, attenuated viruses, their isolated antigens, or their synthetic proteins.
This report studies the global Viral Vector Vaccine for Humans production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Viral Vector Vaccine for Humans, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Vector Vaccine for Humans that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Viral Vector Vaccine for Humans total production and demand, 2019-2030, (K Units)
Global Viral Vector Vaccine for Humans total production value, 2019-2030, (USD Million)
Global Viral Vector Vaccine for Humans production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Viral Vector Vaccine for Humans consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Viral Vector Vaccine for Humans domestic production, consumption, key domestic manufacturers and share
Global Viral Vector Vaccine for Humans production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Viral Vector Vaccine for Humans production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Viral Vector Vaccine for Humans production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Viral Vector Vaccine for Humans market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation and BioMerieux, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Vector Vaccine for Humans market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Viral Vector Vaccine for Humans Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Inactivated Vaccine
- Live Attenuated Vaccine
- Live Vaccine
- Influenza
- HPV
- Hepatitis B
- Measles
- Others
- BD
- Abbot (Alere)
- Quidel
- Roche
- Thermo Fisher Scientific
- Meridian Bioscience
- Analytik Jena
- Princeton BioMeditech Corporation
- BioMerieux
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
- DiaSorin (Focus Diagnostics)
- Wondfo Biotechnology
- Shuo Shi Biology
- Biotech
- Wantai Biotechnology
- Guangzhou Da'an Gene
1. How big is the global Viral Vector Vaccine for Humans market?
2. What is the demand of the global Viral Vector Vaccine for Humans market?
3. What is the year over year growth of the global Viral Vector Vaccine for Humans market?
4. What is the production and production value of the global Viral Vector Vaccine for Humans market?
5. Who are the key producers in the global Viral Vector Vaccine for Humans market?
1 SUPPLY SUMMARY
1.1 Viral Vector Vaccine for Humans Introduction
1.2 World Viral Vector Vaccine for Humans Supply & Forecast
1.2.1 World Viral Vector Vaccine for Humans Production Value (2019 & 2023 & 2030)
1.2.2 World Viral Vector Vaccine for Humans Production (2019-2030)
1.2.3 World Viral Vector Vaccine for Humans Pricing Trends (2019-2030)
1.3 World Viral Vector Vaccine for Humans Production by Region (Based on Production Site)
1.3.1 World Viral Vector Vaccine for Humans Production Value by Region (2019-2030)
1.3.2 World Viral Vector Vaccine for Humans Production by Region (2019-2030)
1.3.3 World Viral Vector Vaccine for Humans Average Price by Region (2019-2030)
1.3.4 North America Viral Vector Vaccine for Humans Production (2019-2030)
1.3.5 Europe Viral Vector Vaccine for Humans Production (2019-2030)
1.3.6 China Viral Vector Vaccine for Humans Production (2019-2030)
1.3.7 Japan Viral Vector Vaccine for Humans Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Vector Vaccine for Humans Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viral Vector Vaccine for Humans Major Market Trends
2 DEMAND SUMMARY
2.1 World Viral Vector Vaccine for Humans Demand (2019-2030)
2.2 World Viral Vector Vaccine for Humans Consumption by Region
2.2.1 World Viral Vector Vaccine for Humans Consumption by Region (2019-2024)
2.2.2 World Viral Vector Vaccine for Humans Consumption Forecast by Region (2025-2030)
2.3 United States Viral Vector Vaccine for Humans Consumption (2019-2030)
2.4 China Viral Vector Vaccine for Humans Consumption (2019-2030)
2.5 Europe Viral Vector Vaccine for Humans Consumption (2019-2030)
2.6 Japan Viral Vector Vaccine for Humans Consumption (2019-2030)
2.7 South Korea Viral Vector Vaccine for Humans Consumption (2019-2030)
2.8 ASEAN Viral Vector Vaccine for Humans Consumption (2019-2030)
2.9 India Viral Vector Vaccine for Humans Consumption (2019-2030)
3 WORLD VIRAL VECTOR VACCINE FOR HUMANS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Viral Vector Vaccine for Humans Production Value by Manufacturer (2019-2024)
3.2 World Viral Vector Vaccine for Humans Production by Manufacturer (2019-2024)
3.3 World Viral Vector Vaccine for Humans Average Price by Manufacturer (2019-2024)
3.4 Viral Vector Vaccine for Humans Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Viral Vector Vaccine for Humans Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Viral Vector Vaccine for Humans in 2023
3.5.3 Global Concentration Ratios (CR8) for Viral Vector Vaccine for Humans in 2023
3.6 Viral Vector Vaccine for Humans Market: Overall Company Footprint Analysis
3.6.1 Viral Vector Vaccine for Humans Market: Region Footprint
3.6.2 Viral Vector Vaccine for Humans Market: Company Product Type Footprint
3.6.3 Viral Vector Vaccine for Humans Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Viral Vector Vaccine for Humans Production Value Comparison
4.1.1 United States VS China: Viral Vector Vaccine for Humans Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Viral Vector Vaccine for Humans Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Viral Vector Vaccine for Humans Production Comparison
4.2.1 United States VS China: Viral Vector Vaccine for Humans Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Viral Vector Vaccine for Humans Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Viral Vector Vaccine for Humans Consumption Comparison
4.3.1 United States VS China: Viral Vector Vaccine for Humans Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Viral Vector Vaccine for Humans Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Viral Vector Vaccine for Humans Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Viral Vector Vaccine for Humans Production Value (2019-2024)
4.4.3 United States Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024)
4.5 China Based Viral Vector Vaccine for Humans Manufacturers and Market Share
4.5.1 China Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Viral Vector Vaccine for Humans Production Value (2019-2024)
4.5.3 China Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024)
4.6 Rest of World Based Viral Vector Vaccine for Humans Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Vector Vaccine for Humans Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Inactivated Vaccine
5.2.2 Live Attenuated Vaccine
5.2.3 Live Vaccine
5.3 Market Segment by Type
5.3.1 World Viral Vector Vaccine for Humans Production by Type (2019-2030)
5.3.2 World Viral Vector Vaccine for Humans Production Value by Type (2019-2030)
5.3.3 World Viral Vector Vaccine for Humans Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viral Vector Vaccine for Humans Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Influenza
6.2.2 HPV
6.2.3 Hepatitis B
6.2.4 Measles
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Viral Vector Vaccine for Humans Production by Application (2019-2030)
6.3.2 World Viral Vector Vaccine for Humans Production Value by Application (2019-2030)
6.3.3 World Viral Vector Vaccine for Humans Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 BD
7.1.1 BD Details
7.1.2 BD Major Business
7.1.3 BD Viral Vector Vaccine for Humans Product and Services
7.1.4 BD Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 BD Recent Developments/Updates
7.1.6 BD Competitive Strengths & Weaknesses
7.2 Abbot (Alere)
7.2.1 Abbot (Alere) Details
7.2.2 Abbot (Alere) Major Business
7.2.3 Abbot (Alere) Viral Vector Vaccine for Humans Product and Services
7.2.4 Abbot (Alere) Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Abbot (Alere) Recent Developments/Updates
7.2.6 Abbot (Alere) Competitive Strengths & Weaknesses
7.3 Quidel
7.3.1 Quidel Details
7.3.2 Quidel Major Business
7.3.3 Quidel Viral Vector Vaccine for Humans Product and Services
7.3.4 Quidel Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Quidel Recent Developments/Updates
7.3.6 Quidel Competitive Strengths & Weaknesses
7.4 Roche
7.4.1 Roche Details
7.4.2 Roche Major Business
7.4.3 Roche Viral Vector Vaccine for Humans Product and Services
7.4.4 Roche Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Roche Recent Developments/Updates
7.4.6 Roche Competitive Strengths & Weaknesses
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Details
7.5.2 Thermo Fisher Scientific Major Business
7.5.3 Thermo Fisher Scientific Viral Vector Vaccine for Humans Product and Services
7.5.4 Thermo Fisher Scientific Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments/Updates
7.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.6 Meridian Bioscience
7.6.1 Meridian Bioscience Details
7.6.2 Meridian Bioscience Major Business
7.6.3 Meridian Bioscience Viral Vector Vaccine for Humans Product and Services
7.6.4 Meridian Bioscience Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Meridian Bioscience Recent Developments/Updates
7.6.6 Meridian Bioscience Competitive Strengths & Weaknesses
7.7 Analytik Jena
7.7.1 Analytik Jena Details
7.7.2 Analytik Jena Major Business
7.7.3 Analytik Jena Viral Vector Vaccine for Humans Product and Services
7.7.4 Analytik Jena Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Analytik Jena Recent Developments/Updates
7.7.6 Analytik Jena Competitive Strengths & Weaknesses
7.8 Princeton BioMeditech Corporation
7.8.1 Princeton BioMeditech Corporation Details
7.8.2 Princeton BioMeditech Corporation Major Business
7.8.3 Princeton BioMeditech Corporation Viral Vector Vaccine for Humans Product and Services
7.8.4 Princeton BioMeditech Corporation Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Princeton BioMeditech Corporation Recent Developments/Updates
7.8.6 Princeton BioMeditech Corporation Competitive Strengths & Weaknesses
7.9 BioMerieux
7.9.1 BioMerieux Details
7.9.2 BioMerieux Major Business
7.9.3 BioMerieux Viral Vector Vaccine for Humans Product and Services
7.9.4 BioMerieux Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 BioMerieux Recent Developments/Updates
7.9.6 BioMerieux Competitive Strengths & Weaknesses
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Details
7.10.2 Sekisui Diagnostics Major Business
7.10.3 Sekisui Diagnostics Viral Vector Vaccine for Humans Product and Services
7.10.4 Sekisui Diagnostics Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Sekisui Diagnostics Recent Developments/Updates
7.10.6 Sekisui Diagnostics Competitive Strengths & Weaknesses
7.11 Response Biomedical
7.11.1 Response Biomedical Details
7.11.2 Response Biomedical Major Business
7.11.3 Response Biomedical Viral Vector Vaccine for Humans Product and Services
7.11.4 Response Biomedical Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Response Biomedical Recent Developments/Updates
7.11.6 Response Biomedical Competitive Strengths & Weaknesses
7.12 SA Scientific
7.12.1 SA Scientific Details
7.12.2 SA Scientific Major Business
7.12.3 SA Scientific Viral Vector Vaccine for Humans Product and Services
7.12.4 SA Scientific Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 SA Scientific Recent Developments/Updates
7.12.6 SA Scientific Competitive Strengths & Weaknesses
7.13 DiaSorin (Focus Diagnostics)
7.13.1 DiaSorin (Focus Diagnostics) Details
7.13.2 DiaSorin (Focus Diagnostics) Major Business
7.13.3 DiaSorin (Focus Diagnostics) Viral Vector Vaccine for Humans Product and Services
7.13.4 DiaSorin (Focus Diagnostics) Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 DiaSorin (Focus Diagnostics) Recent Developments/Updates
7.13.6 DiaSorin (Focus Diagnostics) Competitive Strengths & Weaknesses
7.14 Wondfo Biotechnology
7.14.1 Wondfo Biotechnology Details
7.14.2 Wondfo Biotechnology Major Business
7.14.3 Wondfo Biotechnology Viral Vector Vaccine for Humans Product and Services
7.14.4 Wondfo Biotechnology Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Wondfo Biotechnology Recent Developments/Updates
7.14.6 Wondfo Biotechnology Competitive Strengths & Weaknesses
7.15 Shuo Shi Biology
7.15.1 Shuo Shi Biology Details
7.15.2 Shuo Shi Biology Major Business
7.15.3 Shuo Shi Biology Viral Vector Vaccine for Humans Product and Services
7.15.4 Shuo Shi Biology Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Shuo Shi Biology Recent Developments/Updates
7.15.6 Shuo Shi Biology Competitive Strengths & Weaknesses
7.16 Biotech
7.16.1 Biotech Details
7.16.2 Biotech Major Business
7.16.3 Biotech Viral Vector Vaccine for Humans Product and Services
7.16.4 Biotech Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Biotech Recent Developments/Updates
7.16.6 Biotech Competitive Strengths & Weaknesses
7.17 Wantai Biotechnology
7.17.1 Wantai Biotechnology Details
7.17.2 Wantai Biotechnology Major Business
7.17.3 Wantai Biotechnology Viral Vector Vaccine for Humans Product and Services
7.17.4 Wantai Biotechnology Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Wantai Biotechnology Recent Developments/Updates
7.17.6 Wantai Biotechnology Competitive Strengths & Weaknesses
7.18 Guangzhou Da'an Gene
7.18.1 Guangzhou Da'an Gene Details
7.18.2 Guangzhou Da'an Gene Major Business
7.18.3 Guangzhou Da'an Gene Viral Vector Vaccine for Humans Product and Services
7.18.4 Guangzhou Da'an Gene Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Guangzhou Da'an Gene Recent Developments/Updates
7.18.6 Guangzhou Da'an Gene Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viral Vector Vaccine for Humans Industry Chain
8.2 Viral Vector Vaccine for Humans Upstream Analysis
8.2.1 Viral Vector Vaccine for Humans Core Raw Materials
8.2.2 Main Manufacturers of Viral Vector Vaccine for Humans Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Viral Vector Vaccine for Humans Production Mode
8.6 Viral Vector Vaccine for Humans Procurement Model
8.7 Viral Vector Vaccine for Humans Industry Sales Model and Sales Channels
8.7.1 Viral Vector Vaccine for Humans Sales Model
8.7.2 Viral Vector Vaccine for Humans Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Viral Vector Vaccine for Humans Introduction
1.2 World Viral Vector Vaccine for Humans Supply & Forecast
1.2.1 World Viral Vector Vaccine for Humans Production Value (2019 & 2023 & 2030)
1.2.2 World Viral Vector Vaccine for Humans Production (2019-2030)
1.2.3 World Viral Vector Vaccine for Humans Pricing Trends (2019-2030)
1.3 World Viral Vector Vaccine for Humans Production by Region (Based on Production Site)
1.3.1 World Viral Vector Vaccine for Humans Production Value by Region (2019-2030)
1.3.2 World Viral Vector Vaccine for Humans Production by Region (2019-2030)
1.3.3 World Viral Vector Vaccine for Humans Average Price by Region (2019-2030)
1.3.4 North America Viral Vector Vaccine for Humans Production (2019-2030)
1.3.5 Europe Viral Vector Vaccine for Humans Production (2019-2030)
1.3.6 China Viral Vector Vaccine for Humans Production (2019-2030)
1.3.7 Japan Viral Vector Vaccine for Humans Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Viral Vector Vaccine for Humans Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Viral Vector Vaccine for Humans Major Market Trends
2 DEMAND SUMMARY
2.1 World Viral Vector Vaccine for Humans Demand (2019-2030)
2.2 World Viral Vector Vaccine for Humans Consumption by Region
2.2.1 World Viral Vector Vaccine for Humans Consumption by Region (2019-2024)
2.2.2 World Viral Vector Vaccine for Humans Consumption Forecast by Region (2025-2030)
2.3 United States Viral Vector Vaccine for Humans Consumption (2019-2030)
2.4 China Viral Vector Vaccine for Humans Consumption (2019-2030)
2.5 Europe Viral Vector Vaccine for Humans Consumption (2019-2030)
2.6 Japan Viral Vector Vaccine for Humans Consumption (2019-2030)
2.7 South Korea Viral Vector Vaccine for Humans Consumption (2019-2030)
2.8 ASEAN Viral Vector Vaccine for Humans Consumption (2019-2030)
2.9 India Viral Vector Vaccine for Humans Consumption (2019-2030)
3 WORLD VIRAL VECTOR VACCINE FOR HUMANS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Viral Vector Vaccine for Humans Production Value by Manufacturer (2019-2024)
3.2 World Viral Vector Vaccine for Humans Production by Manufacturer (2019-2024)
3.3 World Viral Vector Vaccine for Humans Average Price by Manufacturer (2019-2024)
3.4 Viral Vector Vaccine for Humans Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Viral Vector Vaccine for Humans Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Viral Vector Vaccine for Humans in 2023
3.5.3 Global Concentration Ratios (CR8) for Viral Vector Vaccine for Humans in 2023
3.6 Viral Vector Vaccine for Humans Market: Overall Company Footprint Analysis
3.6.1 Viral Vector Vaccine for Humans Market: Region Footprint
3.6.2 Viral Vector Vaccine for Humans Market: Company Product Type Footprint
3.6.3 Viral Vector Vaccine for Humans Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Viral Vector Vaccine for Humans Production Value Comparison
4.1.1 United States VS China: Viral Vector Vaccine for Humans Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Viral Vector Vaccine for Humans Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Viral Vector Vaccine for Humans Production Comparison
4.2.1 United States VS China: Viral Vector Vaccine for Humans Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Viral Vector Vaccine for Humans Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Viral Vector Vaccine for Humans Consumption Comparison
4.3.1 United States VS China: Viral Vector Vaccine for Humans Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Viral Vector Vaccine for Humans Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Viral Vector Vaccine for Humans Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Viral Vector Vaccine for Humans Production Value (2019-2024)
4.4.3 United States Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024)
4.5 China Based Viral Vector Vaccine for Humans Manufacturers and Market Share
4.5.1 China Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Viral Vector Vaccine for Humans Production Value (2019-2024)
4.5.3 China Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024)
4.6 Rest of World Based Viral Vector Vaccine for Humans Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Viral Vector Vaccine for Humans Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Inactivated Vaccine
5.2.2 Live Attenuated Vaccine
5.2.3 Live Vaccine
5.3 Market Segment by Type
5.3.1 World Viral Vector Vaccine for Humans Production by Type (2019-2030)
5.3.2 World Viral Vector Vaccine for Humans Production Value by Type (2019-2030)
5.3.3 World Viral Vector Vaccine for Humans Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Viral Vector Vaccine for Humans Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Influenza
6.2.2 HPV
6.2.3 Hepatitis B
6.2.4 Measles
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Viral Vector Vaccine for Humans Production by Application (2019-2030)
6.3.2 World Viral Vector Vaccine for Humans Production Value by Application (2019-2030)
6.3.3 World Viral Vector Vaccine for Humans Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 BD
7.1.1 BD Details
7.1.2 BD Major Business
7.1.3 BD Viral Vector Vaccine for Humans Product and Services
7.1.4 BD Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 BD Recent Developments/Updates
7.1.6 BD Competitive Strengths & Weaknesses
7.2 Abbot (Alere)
7.2.1 Abbot (Alere) Details
7.2.2 Abbot (Alere) Major Business
7.2.3 Abbot (Alere) Viral Vector Vaccine for Humans Product and Services
7.2.4 Abbot (Alere) Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Abbot (Alere) Recent Developments/Updates
7.2.6 Abbot (Alere) Competitive Strengths & Weaknesses
7.3 Quidel
7.3.1 Quidel Details
7.3.2 Quidel Major Business
7.3.3 Quidel Viral Vector Vaccine for Humans Product and Services
7.3.4 Quidel Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Quidel Recent Developments/Updates
7.3.6 Quidel Competitive Strengths & Weaknesses
7.4 Roche
7.4.1 Roche Details
7.4.2 Roche Major Business
7.4.3 Roche Viral Vector Vaccine for Humans Product and Services
7.4.4 Roche Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Roche Recent Developments/Updates
7.4.6 Roche Competitive Strengths & Weaknesses
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Details
7.5.2 Thermo Fisher Scientific Major Business
7.5.3 Thermo Fisher Scientific Viral Vector Vaccine for Humans Product and Services
7.5.4 Thermo Fisher Scientific Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments/Updates
7.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.6 Meridian Bioscience
7.6.1 Meridian Bioscience Details
7.6.2 Meridian Bioscience Major Business
7.6.3 Meridian Bioscience Viral Vector Vaccine for Humans Product and Services
7.6.4 Meridian Bioscience Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Meridian Bioscience Recent Developments/Updates
7.6.6 Meridian Bioscience Competitive Strengths & Weaknesses
7.7 Analytik Jena
7.7.1 Analytik Jena Details
7.7.2 Analytik Jena Major Business
7.7.3 Analytik Jena Viral Vector Vaccine for Humans Product and Services
7.7.4 Analytik Jena Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Analytik Jena Recent Developments/Updates
7.7.6 Analytik Jena Competitive Strengths & Weaknesses
7.8 Princeton BioMeditech Corporation
7.8.1 Princeton BioMeditech Corporation Details
7.8.2 Princeton BioMeditech Corporation Major Business
7.8.3 Princeton BioMeditech Corporation Viral Vector Vaccine for Humans Product and Services
7.8.4 Princeton BioMeditech Corporation Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Princeton BioMeditech Corporation Recent Developments/Updates
7.8.6 Princeton BioMeditech Corporation Competitive Strengths & Weaknesses
7.9 BioMerieux
7.9.1 BioMerieux Details
7.9.2 BioMerieux Major Business
7.9.3 BioMerieux Viral Vector Vaccine for Humans Product and Services
7.9.4 BioMerieux Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 BioMerieux Recent Developments/Updates
7.9.6 BioMerieux Competitive Strengths & Weaknesses
7.10 Sekisui Diagnostics
7.10.1 Sekisui Diagnostics Details
7.10.2 Sekisui Diagnostics Major Business
7.10.3 Sekisui Diagnostics Viral Vector Vaccine for Humans Product and Services
7.10.4 Sekisui Diagnostics Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Sekisui Diagnostics Recent Developments/Updates
7.10.6 Sekisui Diagnostics Competitive Strengths & Weaknesses
7.11 Response Biomedical
7.11.1 Response Biomedical Details
7.11.2 Response Biomedical Major Business
7.11.3 Response Biomedical Viral Vector Vaccine for Humans Product and Services
7.11.4 Response Biomedical Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Response Biomedical Recent Developments/Updates
7.11.6 Response Biomedical Competitive Strengths & Weaknesses
7.12 SA Scientific
7.12.1 SA Scientific Details
7.12.2 SA Scientific Major Business
7.12.3 SA Scientific Viral Vector Vaccine for Humans Product and Services
7.12.4 SA Scientific Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 SA Scientific Recent Developments/Updates
7.12.6 SA Scientific Competitive Strengths & Weaknesses
7.13 DiaSorin (Focus Diagnostics)
7.13.1 DiaSorin (Focus Diagnostics) Details
7.13.2 DiaSorin (Focus Diagnostics) Major Business
7.13.3 DiaSorin (Focus Diagnostics) Viral Vector Vaccine for Humans Product and Services
7.13.4 DiaSorin (Focus Diagnostics) Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 DiaSorin (Focus Diagnostics) Recent Developments/Updates
7.13.6 DiaSorin (Focus Diagnostics) Competitive Strengths & Weaknesses
7.14 Wondfo Biotechnology
7.14.1 Wondfo Biotechnology Details
7.14.2 Wondfo Biotechnology Major Business
7.14.3 Wondfo Biotechnology Viral Vector Vaccine for Humans Product and Services
7.14.4 Wondfo Biotechnology Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Wondfo Biotechnology Recent Developments/Updates
7.14.6 Wondfo Biotechnology Competitive Strengths & Weaknesses
7.15 Shuo Shi Biology
7.15.1 Shuo Shi Biology Details
7.15.2 Shuo Shi Biology Major Business
7.15.3 Shuo Shi Biology Viral Vector Vaccine for Humans Product and Services
7.15.4 Shuo Shi Biology Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Shuo Shi Biology Recent Developments/Updates
7.15.6 Shuo Shi Biology Competitive Strengths & Weaknesses
7.16 Biotech
7.16.1 Biotech Details
7.16.2 Biotech Major Business
7.16.3 Biotech Viral Vector Vaccine for Humans Product and Services
7.16.4 Biotech Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Biotech Recent Developments/Updates
7.16.6 Biotech Competitive Strengths & Weaknesses
7.17 Wantai Biotechnology
7.17.1 Wantai Biotechnology Details
7.17.2 Wantai Biotechnology Major Business
7.17.3 Wantai Biotechnology Viral Vector Vaccine for Humans Product and Services
7.17.4 Wantai Biotechnology Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Wantai Biotechnology Recent Developments/Updates
7.17.6 Wantai Biotechnology Competitive Strengths & Weaknesses
7.18 Guangzhou Da'an Gene
7.18.1 Guangzhou Da'an Gene Details
7.18.2 Guangzhou Da'an Gene Major Business
7.18.3 Guangzhou Da'an Gene Viral Vector Vaccine for Humans Product and Services
7.18.4 Guangzhou Da'an Gene Viral Vector Vaccine for Humans Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Guangzhou Da'an Gene Recent Developments/Updates
7.18.6 Guangzhou Da'an Gene Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Viral Vector Vaccine for Humans Industry Chain
8.2 Viral Vector Vaccine for Humans Upstream Analysis
8.2.1 Viral Vector Vaccine for Humans Core Raw Materials
8.2.2 Main Manufacturers of Viral Vector Vaccine for Humans Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Viral Vector Vaccine for Humans Production Mode
8.6 Viral Vector Vaccine for Humans Procurement Model
8.7 Viral Vector Vaccine for Humans Industry Sales Model and Sales Channels
8.7.1 Viral Vector Vaccine for Humans Sales Model
8.7.2 Viral Vector Vaccine for Humans Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Viral Vector Vaccine for Humans Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Viral Vector Vaccine for Humans Production Value by Region (2019-2024) & (USD Million)
Table 3. World Viral Vector Vaccine for Humans Production Value by Region (2025-2030) & (USD Million)
Table 4. World Viral Vector Vaccine for Humans Production Value Market Share by Region (2019-2024)
Table 5. World Viral Vector Vaccine for Humans Production Value Market Share by Region (2025-2030)
Table 6. World Viral Vector Vaccine for Humans Production by Region (2019-2024) & (K Units)
Table 7. World Viral Vector Vaccine for Humans Production by Region (2025-2030) & (K Units)
Table 8. World Viral Vector Vaccine for Humans Production Market Share by Region (2019-2024)
Table 9. World Viral Vector Vaccine for Humans Production Market Share by Region (2025-2030)
Table 10. World Viral Vector Vaccine for Humans Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Viral Vector Vaccine for Humans Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Viral Vector Vaccine for Humans Major Market Trends
Table 13. World Viral Vector Vaccine for Humans Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Viral Vector Vaccine for Humans Consumption by Region (2019-2024) & (K Units)
Table 15. World Viral Vector Vaccine for Humans Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Viral Vector Vaccine for Humans Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Viral Vector Vaccine for Humans Producers in 2023
Table 18. World Viral Vector Vaccine for Humans Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Viral Vector Vaccine for Humans Producers in 2023
Table 20. World Viral Vector Vaccine for Humans Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Viral Vector Vaccine for Humans Company Evaluation Quadrant
Table 22. World Viral Vector Vaccine for Humans Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Viral Vector Vaccine for Humans Production Site of Key Manufacturer
Table 24. Viral Vector Vaccine for Humans Market: Company Product Type Footprint
Table 25. Viral Vector Vaccine for Humans Market: Company Product Application Footprint
Table 26. Viral Vector Vaccine for Humans Competitive Factors
Table 27. Viral Vector Vaccine for Humans New Entrant and Capacity Expansion Plans
Table 28. Viral Vector Vaccine for Humans Mergers & Acquisitions Activity
Table 29. United States VS China Viral Vector Vaccine for Humans Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Viral Vector Vaccine for Humans Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Viral Vector Vaccine for Humans Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Viral Vector Vaccine for Humans Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Viral Vector Vaccine for Humans Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Viral Vector Vaccine for Humans Production Market Share (2019-2024)
Table 37. China Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Viral Vector Vaccine for Humans Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Viral Vector Vaccine for Humans Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Viral Vector Vaccine for Humans Production Market Share (2019-2024)
Table 42. Rest of World Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Market Share (2019-2024)
Table 47. World Viral Vector Vaccine for Humans Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Viral Vector Vaccine for Humans Production by Type (2019-2024) & (K Units)
Table 49. World Viral Vector Vaccine for Humans Production by Type (2025-2030) & (K Units)
Table 50. World Viral Vector Vaccine for Humans Production Value by Type (2019-2024) & (USD Million)
Table 51. World Viral Vector Vaccine for Humans Production Value by Type (2025-2030) & (USD Million)
Table 52. World Viral Vector Vaccine for Humans Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Viral Vector Vaccine for Humans Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Viral Vector Vaccine for Humans Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Viral Vector Vaccine for Humans Production by Application (2019-2024) & (K Units)
Table 56. World Viral Vector Vaccine for Humans Production by Application (2025-2030) & (K Units)
Table 57. World Viral Vector Vaccine for Humans Production Value by Application (2019-2024) & (USD Million)
Table 58. World Viral Vector Vaccine for Humans Production Value by Application (2025-2030) & (USD Million)
Table 59. World Viral Vector Vaccine for Humans Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Viral Vector Vaccine for Humans Average Price by Application (2025-2030) & (US$/Unit)
Table 61. BD Basic Information, Manufacturing Base and Competitors
Table 62. BD Major Business
Table 63. BD Viral Vector Vaccine for Humans Product and Services
Table 64. BD Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. BD Recent Developments/Updates
Table 66. BD Competitive Strengths & Weaknesses
Table 67. Abbot (Alere) Basic Information, Manufacturing Base and Competitors
Table 68. Abbot (Alere) Major Business
Table 69. Abbot (Alere) Viral Vector Vaccine for Humans Product and Services
Table 70. Abbot (Alere) Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Abbot (Alere) Recent Developments/Updates
Table 72. Abbot (Alere) Competitive Strengths & Weaknesses
Table 73. Quidel Basic Information, Manufacturing Base and Competitors
Table 74. Quidel Major Business
Table 75. Quidel Viral Vector Vaccine for Humans Product and Services
Table 76. Quidel Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Quidel Recent Developments/Updates
Table 78. Quidel Competitive Strengths & Weaknesses
Table 79. Roche Basic Information, Manufacturing Base and Competitors
Table 80. Roche Major Business
Table 81. Roche Viral Vector Vaccine for Humans Product and Services
Table 82. Roche Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Roche Recent Developments/Updates
Table 84. Roche Competitive Strengths & Weaknesses
Table 85. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 86. Thermo Fisher Scientific Major Business
Table 87. Thermo Fisher Scientific Viral Vector Vaccine for Humans Product and Services
Table 88. Thermo Fisher Scientific Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 91. Meridian Bioscience Basic Information, Manufacturing Base and Competitors
Table 92. Meridian Bioscience Major Business
Table 93. Meridian Bioscience Viral Vector Vaccine for Humans Product and Services
Table 94. Meridian Bioscience Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Meridian Bioscience Recent Developments/Updates
Table 96. Meridian Bioscience Competitive Strengths & Weaknesses
Table 97. Analytik Jena Basic Information, Manufacturing Base and Competitors
Table 98. Analytik Jena Major Business
Table 99. Analytik Jena Viral Vector Vaccine for Humans Product and Services
Table 100. Analytik Jena Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Analytik Jena Recent Developments/Updates
Table 102. Analytik Jena Competitive Strengths & Weaknesses
Table 103. Princeton BioMeditech Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Princeton BioMeditech Corporation Major Business
Table 105. Princeton BioMeditech Corporation Viral Vector Vaccine for Humans Product and Services
Table 106. Princeton BioMeditech Corporation Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Princeton BioMeditech Corporation Recent Developments/Updates
Table 108. Princeton BioMeditech Corporation Competitive Strengths & Weaknesses
Table 109. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 110. BioMerieux Major Business
Table 111. BioMerieux Viral Vector Vaccine for Humans Product and Services
Table 112. BioMerieux Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. BioMerieux Recent Developments/Updates
Table 114. BioMerieux Competitive Strengths & Weaknesses
Table 115. Sekisui Diagnostics Basic Information, Manufacturing Base and Competitors
Table 116. Sekisui Diagnostics Major Business
Table 117. Sekisui Diagnostics Viral Vector Vaccine for Humans Product and Services
Table 118. Sekisui Diagnostics Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Sekisui Diagnostics Recent Developments/Updates
Table 120. Sekisui Diagnostics Competitive Strengths & Weaknesses
Table 121. Response Biomedical Basic Information, Manufacturing Base and Competitors
Table 122. Response Biomedical Major Business
Table 123. Response Biomedical Viral Vector Vaccine for Humans Product and Services
Table 124. Response Biomedical Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Response Biomedical Recent Developments/Updates
Table 126. Response Biomedical Competitive Strengths & Weaknesses
Table 127. SA Scientific Basic Information, Manufacturing Base and Competitors
Table 128. SA Scientific Major Business
Table 129. SA Scientific Viral Vector Vaccine for Humans Product and Services
Table 130. SA Scientific Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. SA Scientific Recent Developments/Updates
Table 132. SA Scientific Competitive Strengths & Weaknesses
Table 133. DiaSorin (Focus Diagnostics) Basic Information, Manufacturing Base and Competitors
Table 134. DiaSorin (Focus Diagnostics) Major Business
Table 135. DiaSorin (Focus Diagnostics) Viral Vector Vaccine for Humans Product and Services
Table 136. DiaSorin (Focus Diagnostics) Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. DiaSorin (Focus Diagnostics) Recent Developments/Updates
Table 138. DiaSorin (Focus Diagnostics) Competitive Strengths & Weaknesses
Table 139. Wondfo Biotechnology Basic Information, Manufacturing Base and Competitors
Table 140. Wondfo Biotechnology Major Business
Table 141. Wondfo Biotechnology Viral Vector Vaccine for Humans Product and Services
Table 142. Wondfo Biotechnology Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Wondfo Biotechnology Recent Developments/Updates
Table 144. Wondfo Biotechnology Competitive Strengths & Weaknesses
Table 145. Shuo Shi Biology Basic Information, Manufacturing Base and Competitors
Table 146. Shuo Shi Biology Major Business
Table 147. Shuo Shi Biology Viral Vector Vaccine for Humans Product and Services
Table 148. Shuo Shi Biology Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Shuo Shi Biology Recent Developments/Updates
Table 150. Shuo Shi Biology Competitive Strengths & Weaknesses
Table 151. Biotech Basic Information, Manufacturing Base and Competitors
Table 152. Biotech Major Business
Table 153. Biotech Viral Vector Vaccine for Humans Product and Services
Table 154. Biotech Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Biotech Recent Developments/Updates
Table 156. Biotech Competitive Strengths & Weaknesses
Table 157. Wantai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 158. Wantai Biotechnology Major Business
Table 159. Wantai Biotechnology Viral Vector Vaccine for Humans Product and Services
Table 160. Wantai Biotechnology Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Wantai Biotechnology Recent Developments/Updates
Table 162. Guangzhou Da'an Gene Basic Information, Manufacturing Base and Competitors
Table 163. Guangzhou Da'an Gene Major Business
Table 164. Guangzhou Da'an Gene Viral Vector Vaccine for Humans Product and Services
Table 165. Guangzhou Da'an Gene Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 166. Global Key Players of Viral Vector Vaccine for Humans Upstream (Raw Materials)
Table 167. Viral Vector Vaccine for Humans Typical Customers
Table 168. Viral Vector Vaccine for Humans Typical Distributors
LIST OF FIGURE
Figure 1. Viral Vector Vaccine for Humans Picture
Figure 2. World Viral Vector Vaccine for Humans Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Viral Vector Vaccine for Humans Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 5. World Viral Vector Vaccine for Humans Average Price (2019-2030) & (US$/Unit)
Figure 6. World Viral Vector Vaccine for Humans Production Value Market Share by Region (2019-2030)
Figure 7. World Viral Vector Vaccine for Humans Production Market Share by Region (2019-2030)
Figure 8. North America Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 9. Europe Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 10. China Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 11. Japan Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 12. Viral Vector Vaccine for Humans Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 15. World Viral Vector Vaccine for Humans Consumption Market Share by Region (2019-2030)
Figure 16. United States Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 17. China Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 18. Europe Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 19. Japan Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 20. South Korea Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 22. India Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Viral Vector Vaccine for Humans by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Viral Vector Vaccine for Humans Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Viral Vector Vaccine for Humans Markets in 2023
Figure 26. United States VS China: Viral Vector Vaccine for Humans Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Viral Vector Vaccine for Humans Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Viral Vector Vaccine for Humans Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Viral Vector Vaccine for Humans Production Market Share 2023
Figure 30. China Based Manufacturers Viral Vector Vaccine for Humans Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Market Share 2023
Figure 32. World Viral Vector Vaccine for Humans Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Viral Vector Vaccine for Humans Production Value Market Share by Type in 2023
Figure 34. Inactivated Vaccine
Figure 35. Live Attenuated Vaccine
Figure 36. Live Vaccine
Figure 37. World Viral Vector Vaccine for Humans Production Market Share by Type (2019-2030)
Figure 38. World Viral Vector Vaccine for Humans Production Value Market Share by Type (2019-2030)
Figure 39. World Viral Vector Vaccine for Humans Average Price by Type (2019-2030) & (US$/Unit)
Figure 40. World Viral Vector Vaccine for Humans Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Viral Vector Vaccine for Humans Production Value Market Share by Application in 2023
Figure 42. Influenza
Figure 43. HPV
Figure 44. Hepatitis B
Figure 45. Measles
Figure 46. Others
Figure 47. World Viral Vector Vaccine for Humans Production Market Share by Application (2019-2030)
Figure 48. World Viral Vector Vaccine for Humans Production Value Market Share by Application (2019-2030)
Figure 49. World Viral Vector Vaccine for Humans Average Price by Application (2019-2030) & (US$/Unit)
Figure 50. Viral Vector Vaccine for Humans Industry Chain
Figure 51. Viral Vector Vaccine for Humans Procurement Model
Figure 52. Viral Vector Vaccine for Humans Sales Model
Figure 53. Viral Vector Vaccine for Humans Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Table 1. World Viral Vector Vaccine for Humans Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Viral Vector Vaccine for Humans Production Value by Region (2019-2024) & (USD Million)
Table 3. World Viral Vector Vaccine for Humans Production Value by Region (2025-2030) & (USD Million)
Table 4. World Viral Vector Vaccine for Humans Production Value Market Share by Region (2019-2024)
Table 5. World Viral Vector Vaccine for Humans Production Value Market Share by Region (2025-2030)
Table 6. World Viral Vector Vaccine for Humans Production by Region (2019-2024) & (K Units)
Table 7. World Viral Vector Vaccine for Humans Production by Region (2025-2030) & (K Units)
Table 8. World Viral Vector Vaccine for Humans Production Market Share by Region (2019-2024)
Table 9. World Viral Vector Vaccine for Humans Production Market Share by Region (2025-2030)
Table 10. World Viral Vector Vaccine for Humans Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Viral Vector Vaccine for Humans Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Viral Vector Vaccine for Humans Major Market Trends
Table 13. World Viral Vector Vaccine for Humans Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Viral Vector Vaccine for Humans Consumption by Region (2019-2024) & (K Units)
Table 15. World Viral Vector Vaccine for Humans Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Viral Vector Vaccine for Humans Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Viral Vector Vaccine for Humans Producers in 2023
Table 18. World Viral Vector Vaccine for Humans Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Viral Vector Vaccine for Humans Producers in 2023
Table 20. World Viral Vector Vaccine for Humans Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Viral Vector Vaccine for Humans Company Evaluation Quadrant
Table 22. World Viral Vector Vaccine for Humans Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Viral Vector Vaccine for Humans Production Site of Key Manufacturer
Table 24. Viral Vector Vaccine for Humans Market: Company Product Type Footprint
Table 25. Viral Vector Vaccine for Humans Market: Company Product Application Footprint
Table 26. Viral Vector Vaccine for Humans Competitive Factors
Table 27. Viral Vector Vaccine for Humans New Entrant and Capacity Expansion Plans
Table 28. Viral Vector Vaccine for Humans Mergers & Acquisitions Activity
Table 29. United States VS China Viral Vector Vaccine for Humans Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Viral Vector Vaccine for Humans Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Viral Vector Vaccine for Humans Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Viral Vector Vaccine for Humans Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Viral Vector Vaccine for Humans Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Viral Vector Vaccine for Humans Production Market Share (2019-2024)
Table 37. China Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Viral Vector Vaccine for Humans Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Viral Vector Vaccine for Humans Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Viral Vector Vaccine for Humans Production Market Share (2019-2024)
Table 42. Rest of World Based Viral Vector Vaccine for Humans Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Market Share (2019-2024)
Table 47. World Viral Vector Vaccine for Humans Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Viral Vector Vaccine for Humans Production by Type (2019-2024) & (K Units)
Table 49. World Viral Vector Vaccine for Humans Production by Type (2025-2030) & (K Units)
Table 50. World Viral Vector Vaccine for Humans Production Value by Type (2019-2024) & (USD Million)
Table 51. World Viral Vector Vaccine for Humans Production Value by Type (2025-2030) & (USD Million)
Table 52. World Viral Vector Vaccine for Humans Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Viral Vector Vaccine for Humans Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Viral Vector Vaccine for Humans Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Viral Vector Vaccine for Humans Production by Application (2019-2024) & (K Units)
Table 56. World Viral Vector Vaccine for Humans Production by Application (2025-2030) & (K Units)
Table 57. World Viral Vector Vaccine for Humans Production Value by Application (2019-2024) & (USD Million)
Table 58. World Viral Vector Vaccine for Humans Production Value by Application (2025-2030) & (USD Million)
Table 59. World Viral Vector Vaccine for Humans Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Viral Vector Vaccine for Humans Average Price by Application (2025-2030) & (US$/Unit)
Table 61. BD Basic Information, Manufacturing Base and Competitors
Table 62. BD Major Business
Table 63. BD Viral Vector Vaccine for Humans Product and Services
Table 64. BD Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. BD Recent Developments/Updates
Table 66. BD Competitive Strengths & Weaknesses
Table 67. Abbot (Alere) Basic Information, Manufacturing Base and Competitors
Table 68. Abbot (Alere) Major Business
Table 69. Abbot (Alere) Viral Vector Vaccine for Humans Product and Services
Table 70. Abbot (Alere) Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Abbot (Alere) Recent Developments/Updates
Table 72. Abbot (Alere) Competitive Strengths & Weaknesses
Table 73. Quidel Basic Information, Manufacturing Base and Competitors
Table 74. Quidel Major Business
Table 75. Quidel Viral Vector Vaccine for Humans Product and Services
Table 76. Quidel Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Quidel Recent Developments/Updates
Table 78. Quidel Competitive Strengths & Weaknesses
Table 79. Roche Basic Information, Manufacturing Base and Competitors
Table 80. Roche Major Business
Table 81. Roche Viral Vector Vaccine for Humans Product and Services
Table 82. Roche Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Roche Recent Developments/Updates
Table 84. Roche Competitive Strengths & Weaknesses
Table 85. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 86. Thermo Fisher Scientific Major Business
Table 87. Thermo Fisher Scientific Viral Vector Vaccine for Humans Product and Services
Table 88. Thermo Fisher Scientific Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 91. Meridian Bioscience Basic Information, Manufacturing Base and Competitors
Table 92. Meridian Bioscience Major Business
Table 93. Meridian Bioscience Viral Vector Vaccine for Humans Product and Services
Table 94. Meridian Bioscience Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Meridian Bioscience Recent Developments/Updates
Table 96. Meridian Bioscience Competitive Strengths & Weaknesses
Table 97. Analytik Jena Basic Information, Manufacturing Base and Competitors
Table 98. Analytik Jena Major Business
Table 99. Analytik Jena Viral Vector Vaccine for Humans Product and Services
Table 100. Analytik Jena Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Analytik Jena Recent Developments/Updates
Table 102. Analytik Jena Competitive Strengths & Weaknesses
Table 103. Princeton BioMeditech Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Princeton BioMeditech Corporation Major Business
Table 105. Princeton BioMeditech Corporation Viral Vector Vaccine for Humans Product and Services
Table 106. Princeton BioMeditech Corporation Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Princeton BioMeditech Corporation Recent Developments/Updates
Table 108. Princeton BioMeditech Corporation Competitive Strengths & Weaknesses
Table 109. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 110. BioMerieux Major Business
Table 111. BioMerieux Viral Vector Vaccine for Humans Product and Services
Table 112. BioMerieux Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. BioMerieux Recent Developments/Updates
Table 114. BioMerieux Competitive Strengths & Weaknesses
Table 115. Sekisui Diagnostics Basic Information, Manufacturing Base and Competitors
Table 116. Sekisui Diagnostics Major Business
Table 117. Sekisui Diagnostics Viral Vector Vaccine for Humans Product and Services
Table 118. Sekisui Diagnostics Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Sekisui Diagnostics Recent Developments/Updates
Table 120. Sekisui Diagnostics Competitive Strengths & Weaknesses
Table 121. Response Biomedical Basic Information, Manufacturing Base and Competitors
Table 122. Response Biomedical Major Business
Table 123. Response Biomedical Viral Vector Vaccine for Humans Product and Services
Table 124. Response Biomedical Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Response Biomedical Recent Developments/Updates
Table 126. Response Biomedical Competitive Strengths & Weaknesses
Table 127. SA Scientific Basic Information, Manufacturing Base and Competitors
Table 128. SA Scientific Major Business
Table 129. SA Scientific Viral Vector Vaccine for Humans Product and Services
Table 130. SA Scientific Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. SA Scientific Recent Developments/Updates
Table 132. SA Scientific Competitive Strengths & Weaknesses
Table 133. DiaSorin (Focus Diagnostics) Basic Information, Manufacturing Base and Competitors
Table 134. DiaSorin (Focus Diagnostics) Major Business
Table 135. DiaSorin (Focus Diagnostics) Viral Vector Vaccine for Humans Product and Services
Table 136. DiaSorin (Focus Diagnostics) Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. DiaSorin (Focus Diagnostics) Recent Developments/Updates
Table 138. DiaSorin (Focus Diagnostics) Competitive Strengths & Weaknesses
Table 139. Wondfo Biotechnology Basic Information, Manufacturing Base and Competitors
Table 140. Wondfo Biotechnology Major Business
Table 141. Wondfo Biotechnology Viral Vector Vaccine for Humans Product and Services
Table 142. Wondfo Biotechnology Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Wondfo Biotechnology Recent Developments/Updates
Table 144. Wondfo Biotechnology Competitive Strengths & Weaknesses
Table 145. Shuo Shi Biology Basic Information, Manufacturing Base and Competitors
Table 146. Shuo Shi Biology Major Business
Table 147. Shuo Shi Biology Viral Vector Vaccine for Humans Product and Services
Table 148. Shuo Shi Biology Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 149. Shuo Shi Biology Recent Developments/Updates
Table 150. Shuo Shi Biology Competitive Strengths & Weaknesses
Table 151. Biotech Basic Information, Manufacturing Base and Competitors
Table 152. Biotech Major Business
Table 153. Biotech Viral Vector Vaccine for Humans Product and Services
Table 154. Biotech Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 155. Biotech Recent Developments/Updates
Table 156. Biotech Competitive Strengths & Weaknesses
Table 157. Wantai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 158. Wantai Biotechnology Major Business
Table 159. Wantai Biotechnology Viral Vector Vaccine for Humans Product and Services
Table 160. Wantai Biotechnology Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 161. Wantai Biotechnology Recent Developments/Updates
Table 162. Guangzhou Da'an Gene Basic Information, Manufacturing Base and Competitors
Table 163. Guangzhou Da'an Gene Major Business
Table 164. Guangzhou Da'an Gene Viral Vector Vaccine for Humans Product and Services
Table 165. Guangzhou Da'an Gene Viral Vector Vaccine for Humans Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 166. Global Key Players of Viral Vector Vaccine for Humans Upstream (Raw Materials)
Table 167. Viral Vector Vaccine for Humans Typical Customers
Table 168. Viral Vector Vaccine for Humans Typical Distributors
LIST OF FIGURE
Figure 1. Viral Vector Vaccine for Humans Picture
Figure 2. World Viral Vector Vaccine for Humans Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Viral Vector Vaccine for Humans Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 5. World Viral Vector Vaccine for Humans Average Price (2019-2030) & (US$/Unit)
Figure 6. World Viral Vector Vaccine for Humans Production Value Market Share by Region (2019-2030)
Figure 7. World Viral Vector Vaccine for Humans Production Market Share by Region (2019-2030)
Figure 8. North America Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 9. Europe Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 10. China Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 11. Japan Viral Vector Vaccine for Humans Production (2019-2030) & (K Units)
Figure 12. Viral Vector Vaccine for Humans Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 15. World Viral Vector Vaccine for Humans Consumption Market Share by Region (2019-2030)
Figure 16. United States Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 17. China Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 18. Europe Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 19. Japan Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 20. South Korea Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 22. India Viral Vector Vaccine for Humans Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Viral Vector Vaccine for Humans by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Viral Vector Vaccine for Humans Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Viral Vector Vaccine for Humans Markets in 2023
Figure 26. United States VS China: Viral Vector Vaccine for Humans Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Viral Vector Vaccine for Humans Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Viral Vector Vaccine for Humans Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Viral Vector Vaccine for Humans Production Market Share 2023
Figure 30. China Based Manufacturers Viral Vector Vaccine for Humans Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Viral Vector Vaccine for Humans Production Market Share 2023
Figure 32. World Viral Vector Vaccine for Humans Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Viral Vector Vaccine for Humans Production Value Market Share by Type in 2023
Figure 34. Inactivated Vaccine
Figure 35. Live Attenuated Vaccine
Figure 36. Live Vaccine
Figure 37. World Viral Vector Vaccine for Humans Production Market Share by Type (2019-2030)
Figure 38. World Viral Vector Vaccine for Humans Production Value Market Share by Type (2019-2030)
Figure 39. World Viral Vector Vaccine for Humans Average Price by Type (2019-2030) & (US$/Unit)
Figure 40. World Viral Vector Vaccine for Humans Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Viral Vector Vaccine for Humans Production Value Market Share by Application in 2023
Figure 42. Influenza
Figure 43. HPV
Figure 44. Hepatitis B
Figure 45. Measles
Figure 46. Others
Figure 47. World Viral Vector Vaccine for Humans Production Market Share by Application (2019-2030)
Figure 48. World Viral Vector Vaccine for Humans Production Value Market Share by Application (2019-2030)
Figure 49. World Viral Vector Vaccine for Humans Average Price by Application (2019-2030) & (US$/Unit)
Figure 50. Viral Vector Vaccine for Humans Industry Chain
Figure 51. Viral Vector Vaccine for Humans Procurement Model
Figure 52. Viral Vector Vaccine for Humans Sales Model
Figure 53. Viral Vector Vaccine for Humans Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
